Keiretsu Capital

Healionics Corporation is a clinical-stage company based in Seattle, Washington, specializing in the development and manufacture of synthetic biomaterials and implantable medical devices. Founded in 2007, Healionics focuses on addressing critical healthcare challenges, particularly for kidney failure patients requiring dialysis. The company's flagship product, STARgraft, is a synthetic vascular graft designed to provide long-term, reliable blood flow access without the need for frequent interventions, thereby improving patient outcomes and reducing healthcare costs. Additionally, Healionics is developing STARport HD, an implantable device that facilitates needle-free bloodstream access for dialysis, and employs a unique biomaterial technology that enhances the performance of various medical implants by preventing infection and fibrous encapsulation. The company has a robust patent portfolio and established production capabilities, positioning it to enter human clinical studies and market launch in the near future.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

Votegrity is a Seattle-based company founded in 2020 that specializes in online election services, providing a platform designed to enhance voter accessibility and confidence. By leveraging end-to-end verification and cryptographic technology, Votegrity ensures that both voters and election administrators can trust the integrity of the electoral process while safeguarding voter privacy. The platform allows voters to cast their ballots conveniently from computers or smart devices, thereby promoting informed participation in elections. Additionally, Votegrity's approach contributes to environmental sustainability by reducing paper usage associated with traditional voting methods.

ActX, Inc. is a Seattle-based company founded in 2012 that specializes in providing actionable genomic information to healthcare professionals. The company focuses on integrating patient genetic data into everyday medical practice, allowing physicians to access relevant clinical information that can enhance personalized patient care. ActX collects and analyzes saliva samples to generate this genetic information, ensuring the secure and private storage of genomic data. By delivering this information through electronic medical records or a secure website, ActX aims to improve healthcare outcomes and facilitate informed decision-making for medical practitioners.

Loopr AI, founded in 2021 and based in Bellevue, Washington, offers a no-code artificial intelligence platform aimed at streamlining business automation for organizations of various sizes. The platform allows businesses to implement pre-built AI solutions quickly, often within hours or days, facilitating the resolution of complex challenges through AI-driven processes and advanced machine learning techniques. By leveraging Loopr AI's tools, organizations can enhance quality, reduce operational costs, and automate a wide range of processes across different industries and functions.

React Mobile is a safety technology company that provides enterprise employee safety solutions for hospitality, healthcare, transportation, education, and logistics. Its staff safety platform delivers GPS-based alerts and rapid resource deployment, allowing management to notify emergency contacts by text and email with the option to post updates on social media, and to dispatch help to the exact location within seconds. The offering includes the React Sidekick personal panic button and Follow-Me location sharing to keep workers connected during incidents, and hospitality-focused safety packages that address on-site safety workflows for workers such as hotel staff. Founded in 2011 and based in Seattle, React Mobile serves organizations seeking to improve worker safety and emergency response times.

Votegrity is a Seattle-based company founded in 2020 that specializes in online election services, providing a platform designed to enhance voter accessibility and confidence. By leveraging end-to-end verification and cryptographic technology, Votegrity ensures that both voters and election administrators can trust the integrity of the electoral process while safeguarding voter privacy. The platform allows voters to cast their ballots conveniently from computers or smart devices, thereby promoting informed participation in elections. Additionally, Votegrity's approach contributes to environmental sustainability by reducing paper usage associated with traditional voting methods.

Founded in 2006, Inmedix specializes in developing diagnostics and therapeutics for autoimmune diseases. The company focuses on assessing, optimizing, and maintaining the autonomic nervous system's control of stress responses within the brain to mitigate autoimmune disease progression.

ActX, Inc. is a Seattle-based company founded in 2012 that specializes in providing actionable genomic information to healthcare professionals. The company focuses on integrating patient genetic data into everyday medical practice, allowing physicians to access relevant clinical information that can enhance personalized patient care. ActX collects and analyzes saliva samples to generate this genetic information, ensuring the secure and private storage of genomic data. By delivering this information through electronic medical records or a secure website, ActX aims to improve healthcare outcomes and facilitate informed decision-making for medical practitioners.

LumiThera is a medical device company that develops photobiomodulation-based treatments for ocular diseases. It seeks to prevent vision loss and slow disease progression by using non-invasive light therapy delivered through LED-based systems, including The Valeda light delivery system for dry age-related macular degeneration and other ocular disorders. The technology aims to improve visual function, acuity, and contrast sensitivity while reducing disease activity. Founded in 2013, LumiThera is headquartered in Poulsbo, Washington.

KitoTech Medical, Inc. is a medical device company based in Seattle, Washington, specializing in the development and commercialization of innovative products for wound closure and care. Established in 2011, the company has introduced microMend, a proprietary wound closure device featuring tiny Microstaples on an adhesive backing, designed for ease of application similar to a bandage. microMend is painless to use and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in terms of clinical outcomes, including cosmetic results, and allows for quicker application by various medical personnel, resulting in considerable cost savings. The product is marketed across a range of surgical specialties, as well as in dermatology and emergency medicine, with additional opportunities in military applications. KitoTech Medical targets a potential market exceeding $600 million in the US and $2 billion worldwide.

Pathware is a technology company developing a digital pathology platform for point-of-care diagnostics. The platform combines computational microscopy and artificial intelligence to analyze tissue samples, enabling clinicians and pathologists to diagnose and treat diseases earlier and more precisely, with the goal of improving patient outcomes and reducing diagnostic times. Its product set includes Bioptic, an automated point-of-care biopsy assessment system, along with a sample testing platform and a sample management platform designed to streamline pathology workflows. Founded in 2017 and based in Ann Arbor, Michigan, with an additional location in Seattle, Pathware focuses on bringing computational pathology tools to the bedside to support faster, more accurate decision making in healthcare.

HaptX is a technology company focused on enhancing virtual reality experiences through realistic touch simulation. It has developed HaptX Gloves, which enable natural interaction and provide haptic feedback with a high level of realism. Utilizing patented microfluidic technology, these gloves feature 130 points of touch feedback and can apply resistive force feedback of up to 4 pounds per finger, while also tracking hand motions with sub-millimeter precision. Founded by Jake Rubin and Dr. Bob Crockett, HaptX employs a team of 35 and operates from offices in Seattle, Washington, and San Luis Obispo, California. The company's innovations allow users to feel the texture, shape, motion, vibration, and temperature of virtual objects, bridging the gap between the physical and virtual worlds.

Joule Case manufactures innovative battery modules and control systems. Its products empower mobility across various sectors by providing scalable, emission-minimizing energy solutions. Joule Case's offerings include the P600/P1200 control modules and Li500/Li3.5k battery modules, designed to overcome energy infrastructure limitations in settings like live events, EV fleets, construction sites, and food & beverage services.

Pattern Computer is a pattern discovery company that develops a proprietary system and platform to uncover novel patterns in complex data. The technology generates hypotheses and insights that can transform research and business, and is applied in areas such as breast cancer prognostics and the detection of healthy versus disease-state pathways in microbiome and human gut disorders. Founded in 2015 and headquartered in Friday Harbor, Washington, the company focuses on solving difficult and entrenched problems that conventional tools cannot address.

Healionics Corporation is a clinical-stage company based in Seattle, Washington, specializing in the development and manufacture of synthetic biomaterials and implantable medical devices. Founded in 2007, Healionics focuses on addressing critical healthcare challenges, particularly for kidney failure patients requiring dialysis. The company's flagship product, STARgraft, is a synthetic vascular graft designed to provide long-term, reliable blood flow access without the need for frequent interventions, thereby improving patient outcomes and reducing healthcare costs. Additionally, Healionics is developing STARport HD, an implantable device that facilitates needle-free bloodstream access for dialysis, and employs a unique biomaterial technology that enhances the performance of various medical implants by preventing infection and fibrous encapsulation. The company has a robust patent portfolio and established production capabilities, positioning it to enter human clinical studies and market launch in the near future.

Tilting Motor Works, Inc. is a company based in Snohomish, Washington, specializing in the development of leaning three-wheel conversion solutions for motorcycles. Founded in 2008, the company focuses on enhancing motorcycle performance while prioritizing safety and stability. Its innovative conversion process replaces the traditional front fork and wheel with a new front end that integrates various components such as leaning linkages, shocks, wheels, tires, fenders, brakes, hydraulics, front fairings, and mounting hardware. This patented retrofit is designed to provide riders with a higher-performing motorcycle that delivers improved handling and confidence.

Founded in 2006, Inmedix specializes in developing diagnostics and therapeutics for autoimmune diseases. The company focuses on assessing, optimizing, and maintaining the autonomic nervous system's control of stress responses within the brain to mitigate autoimmune disease progression.

Healionics Corporation is a clinical-stage company based in Seattle, Washington, specializing in the development and manufacture of synthetic biomaterials and implantable medical devices. Founded in 2007, Healionics focuses on addressing critical healthcare challenges, particularly for kidney failure patients requiring dialysis. The company's flagship product, STARgraft, is a synthetic vascular graft designed to provide long-term, reliable blood flow access without the need for frequent interventions, thereby improving patient outcomes and reducing healthcare costs. Additionally, Healionics is developing STARport HD, an implantable device that facilitates needle-free bloodstream access for dialysis, and employs a unique biomaterial technology that enhances the performance of various medical implants by preventing infection and fibrous encapsulation. The company has a robust patent portfolio and established production capabilities, positioning it to enter human clinical studies and market launch in the near future.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound-based medical devices aimed at diagnosing middle ear infections, known as otitis media, in both children and adults. The company has created a patented handheld device that allows clinicians to swiftly and accurately distinguish between viral and bacterial infections, thereby informing appropriate treatment decisions regarding antibiotic use. This innovative application of ultrasound technology facilitates rapid data collection, enabling ease of use by healthcare professionals, including non-physician personnel. Additionally, the device features one-use-per-patient tips, which contribute to a recurring revenue model for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus was previously known as OtoMetrix Medical Technologies until its name change in July 2014.

KitoTech Medical, Inc. is a medical device company based in Seattle, Washington, specializing in the development and commercialization of innovative products for wound closure and care. Established in 2011, the company has introduced microMend, a proprietary wound closure device featuring tiny Microstaples on an adhesive backing, designed for ease of application similar to a bandage. microMend is painless to use and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in terms of clinical outcomes, including cosmetic results, and allows for quicker application by various medical personnel, resulting in considerable cost savings. The product is marketed across a range of surgical specialties, as well as in dermatology and emergency medicine, with additional opportunities in military applications. KitoTech Medical targets a potential market exceeding $600 million in the US and $2 billion worldwide.

CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company specializes in developing innovative solutions for pelvic fracture repair, addressing unmet needs in orthopedic trauma. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to adapt to the natural shape of bones, particularly in the pelvis. This capability allows the device to effectively fill the space within curved bones, facilitating simpler and shorter surgical procedures. By improving surgical outcomes, CurvaFix aims to enhance patient recovery times and overall treatment efficacy.

LumiThera is a medical device company that develops photobiomodulation-based treatments for ocular diseases. It seeks to prevent vision loss and slow disease progression by using non-invasive light therapy delivered through LED-based systems, including The Valeda light delivery system for dry age-related macular degeneration and other ocular disorders. The technology aims to improve visual function, acuity, and contrast sensitivity while reducing disease activity. Founded in 2013, LumiThera is headquartered in Poulsbo, Washington.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

StormSensor, Inc. is a Seattle-based company that specializes in stormwater management solutions aimed at preventing flooding, sewage overflows, and other stormwater issues. Founded in 2015, StormSensor develops Scute sensors that provide real-time monitoring of conditions within stormwater systems. The company also offers Terrapin, a cloud-based software platform that facilitates data visualization, integrates weather data, and sends alerts for significant flow events. This platform automates workflows for inspections, data monitoring, and regulatory reporting, significantly reducing the manual processes traditionally used by clients to maintain compliance in a complex regulatory landscape. By providing essential information on urban flooding, illicit discharges, and infrastructure impacts from climate change, StormSensor enables its clients to effectively respond to and mitigate climate-driven risks.

Founded in 2006, Inmedix specializes in developing diagnostics and therapeutics for autoimmune diseases. The company focuses on assessing, optimizing, and maintaining the autonomic nervous system's control of stress responses within the brain to mitigate autoimmune disease progression.

HaptX is a technology company focused on enhancing virtual reality experiences through realistic touch simulation. It has developed HaptX Gloves, which enable natural interaction and provide haptic feedback with a high level of realism. Utilizing patented microfluidic technology, these gloves feature 130 points of touch feedback and can apply resistive force feedback of up to 4 pounds per finger, while also tracking hand motions with sub-millimeter precision. Founded by Jake Rubin and Dr. Bob Crockett, HaptX employs a team of 35 and operates from offices in Seattle, Washington, and San Luis Obispo, California. The company's innovations allow users to feel the texture, shape, motion, vibration, and temperature of virtual objects, bridging the gap between the physical and virtual worlds.

HaptX is a technology company focused on enhancing virtual reality experiences through realistic touch simulation. It has developed HaptX Gloves, which enable natural interaction and provide haptic feedback with a high level of realism. Utilizing patented microfluidic technology, these gloves feature 130 points of touch feedback and can apply resistive force feedback of up to 4 pounds per finger, while also tracking hand motions with sub-millimeter precision. Founded by Jake Rubin and Dr. Bob Crockett, HaptX employs a team of 35 and operates from offices in Seattle, Washington, and San Luis Obispo, California. The company's innovations allow users to feel the texture, shape, motion, vibration, and temperature of virtual objects, bridging the gap between the physical and virtual worlds.

Varidi, Inc. is a cloud-based payment platform that enables businesses to provide flexible direct-to-consumer financing options. Founded in 2013 and headquartered in Woodinville, Washington, Varidi's solution includes a suite of payment and cash flow products designed to streamline payment management, reduce administrative costs, and enhance accounting efficiency. The platform supports e-invoicing, pay-now, and pay-over-time functionalities, allowing businesses to accommodate a variety of customer payment preferences. By automating invoicing and offering guaranteed payment plans, Varidi helps businesses minimize overhead costs and reduce bad debt while increasing revenue and customer loyalty. This comprehensive payment management system positions Varidi as a valuable partner for businesses looking to improve their financial accessibility and operational effectiveness.

Joule Case manufactures innovative battery modules and control systems. Its products empower mobility across various sectors by providing scalable, emission-minimizing energy solutions. Joule Case's offerings include the P600/P1200 control modules and Li500/Li3.5k battery modules, designed to overcome energy infrastructure limitations in settings like live events, EV fleets, construction sites, and food & beverage services.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, specializing in the manufacturing and marketing of face mask solutions designed for CO2 sampling in sidestream capnography during sedation anesthesia. Established in 2012, the company serves a variety of healthcare settings, including hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Monitor Mask's primary product line includes the CapnoVue series, which facilitates capnography monitoring to enhance patient safety and streamline clinical workflows. By incorporating pre-formed ports in their designs, these masks enable accurate assessments of carbon dioxide levels in patients' breaths, thereby assisting clinicians in ensuring adequate oxygen supply and meeting established monitoring standards. As of 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

Teadora, LLC is a manufacturer of natural personal care products based in Bellevue, Washington. Founded in 2015, the company specializes in crafting a distinctive line of body, hair, and skincare products that incorporate natural and organic ingredients, particularly focusing on anti-aging superfruits sourced from the rainforest. Teadora's product offerings include cleansers, shampoos, conditioners, exfoliating and tonic bars, and moisturizing oils, all designed to promote skin and hair health while utilizing sustainable and antioxidant-rich components. The company sells its products online, catering to consumers seeking effective and eco-friendly beauty and wellness solutions.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company specializes in developing innovative solutions for pelvic fracture repair, addressing unmet needs in orthopedic trauma. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to adapt to the natural shape of bones, particularly in the pelvis. This capability allows the device to effectively fill the space within curved bones, facilitating simpler and shorter surgical procedures. By improving surgical outcomes, CurvaFix aims to enhance patient recovery times and overall treatment efficacy.

ActX, Inc. is a Seattle-based company founded in 2012 that specializes in providing actionable genomic information to healthcare professionals. The company focuses on integrating patient genetic data into everyday medical practice, allowing physicians to access relevant clinical information that can enhance personalized patient care. ActX collects and analyzes saliva samples to generate this genetic information, ensuring the secure and private storage of genomic data. By delivering this information through electronic medical records or a secure website, ActX aims to improve healthcare outcomes and facilitate informed decision-making for medical practitioners.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound-based medical devices aimed at diagnosing middle ear infections, known as otitis media, in both children and adults. The company has created a patented handheld device that allows clinicians to swiftly and accurately distinguish between viral and bacterial infections, thereby informing appropriate treatment decisions regarding antibiotic use. This innovative application of ultrasound technology facilitates rapid data collection, enabling ease of use by healthcare professionals, including non-physician personnel. Additionally, the device features one-use-per-patient tips, which contribute to a recurring revenue model for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus was previously known as OtoMetrix Medical Technologies until its name change in July 2014.

Pattern Computer is a pattern discovery company that develops a proprietary system and platform to uncover novel patterns in complex data. The technology generates hypotheses and insights that can transform research and business, and is applied in areas such as breast cancer prognostics and the detection of healthy versus disease-state pathways in microbiome and human gut disorders. Founded in 2015 and headquartered in Friday Harbor, Washington, the company focuses on solving difficult and entrenched problems that conventional tools cannot address.

Pathware is a technology company developing a digital pathology platform for point-of-care diagnostics. The platform combines computational microscopy and artificial intelligence to analyze tissue samples, enabling clinicians and pathologists to diagnose and treat diseases earlier and more precisely, with the goal of improving patient outcomes and reducing diagnostic times. Its product set includes Bioptic, an automated point-of-care biopsy assessment system, along with a sample testing platform and a sample management platform designed to streamline pathology workflows. Founded in 2017 and based in Ann Arbor, Michigan, with an additional location in Seattle, Pathware focuses on bringing computational pathology tools to the bedside to support faster, more accurate decision making in healthcare.

Healionics Corporation is a clinical-stage company based in Seattle, Washington, specializing in the development and manufacture of synthetic biomaterials and implantable medical devices. Founded in 2007, Healionics focuses on addressing critical healthcare challenges, particularly for kidney failure patients requiring dialysis. The company's flagship product, STARgraft, is a synthetic vascular graft designed to provide long-term, reliable blood flow access without the need for frequent interventions, thereby improving patient outcomes and reducing healthcare costs. Additionally, Healionics is developing STARport HD, an implantable device that facilitates needle-free bloodstream access for dialysis, and employs a unique biomaterial technology that enhances the performance of various medical implants by preventing infection and fibrous encapsulation. The company has a robust patent portfolio and established production capabilities, positioning it to enter human clinical studies and market launch in the near future.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

HaptX is a technology company focused on enhancing virtual reality experiences through realistic touch simulation. It has developed HaptX Gloves, which enable natural interaction and provide haptic feedback with a high level of realism. Utilizing patented microfluidic technology, these gloves feature 130 points of touch feedback and can apply resistive force feedback of up to 4 pounds per finger, while also tracking hand motions with sub-millimeter precision. Founded by Jake Rubin and Dr. Bob Crockett, HaptX employs a team of 35 and operates from offices in Seattle, Washington, and San Luis Obispo, California. The company's innovations allow users to feel the texture, shape, motion, vibration, and temperature of virtual objects, bridging the gap between the physical and virtual worlds.

StormSensor, Inc. is a Seattle-based company that specializes in stormwater management solutions aimed at preventing flooding, sewage overflows, and other stormwater issues. Founded in 2015, StormSensor develops Scute sensors that provide real-time monitoring of conditions within stormwater systems. The company also offers Terrapin, a cloud-based software platform that facilitates data visualization, integrates weather data, and sends alerts for significant flow events. This platform automates workflows for inspections, data monitoring, and regulatory reporting, significantly reducing the manual processes traditionally used by clients to maintain compliance in a complex regulatory landscape. By providing essential information on urban flooding, illicit discharges, and infrastructure impacts from climate change, StormSensor enables its clients to effectively respond to and mitigate climate-driven risks.

Varidi, Inc. is a cloud-based payment platform that enables businesses to provide flexible direct-to-consumer financing options. Founded in 2013 and headquartered in Woodinville, Washington, Varidi's solution includes a suite of payment and cash flow products designed to streamline payment management, reduce administrative costs, and enhance accounting efficiency. The platform supports e-invoicing, pay-now, and pay-over-time functionalities, allowing businesses to accommodate a variety of customer payment preferences. By automating invoicing and offering guaranteed payment plans, Varidi helps businesses minimize overhead costs and reduce bad debt while increasing revenue and customer loyalty. This comprehensive payment management system positions Varidi as a valuable partner for businesses looking to improve their financial accessibility and operational effectiveness.

ActX, Inc. is a Seattle-based company founded in 2012 that specializes in providing actionable genomic information to healthcare professionals. The company focuses on integrating patient genetic data into everyday medical practice, allowing physicians to access relevant clinical information that can enhance personalized patient care. ActX collects and analyzes saliva samples to generate this genetic information, ensuring the secure and private storage of genomic data. By delivering this information through electronic medical records or a secure website, ActX aims to improve healthcare outcomes and facilitate informed decision-making for medical practitioners.

CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company specializes in developing innovative solutions for pelvic fracture repair, addressing unmet needs in orthopedic trauma. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to adapt to the natural shape of bones, particularly in the pelvis. This capability allows the device to effectively fill the space within curved bones, facilitating simpler and shorter surgical procedures. By improving surgical outcomes, CurvaFix aims to enhance patient recovery times and overall treatment efficacy.

Beta Hatch Inc. specializes in the production of insect protein primarily for animal feed and also produces nutrient-balanced fertilizers as a by-product of its operations. Founded in 2015 and headquartered in Cashmere, Washington, the company focuses on farming mealworms and utilizes rearing technology that converts organic waste, such as spent brewery grains, into high-quality insect feed. In addition to animal feed, Beta Hatch explores the potential applications of insect exoskeletons in bioplastics and pharmaceuticals. With a commitment to sustainable practices, the company aims to create a zero-waste system while addressing the growing global demand for efficient agricultural solutions. Beta Hatch serves a diverse clientele, including farmers, ranchers, and researchers, leveraging its expertise in entomology to promote the use of insects as a viable commodity crop in food and fertilizer applications.

Tech Traks is a company based in Washington, USA, specializing in digital security enhancements for identification badges. It develops access control devices that utilize magnetic attachments, audible alerts, and Bluetooth Low Energy mesh networking to enable real-time location tracking of ID badges. This technology helps employees keep track of their badges, providing notifications if a badge is separated from the device. Additionally, Tech Traks' solutions allow clients to locate lost badges and disable access cards when necessary, thereby enhancing the security of facilities and improving overall access control management.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound-based medical devices aimed at diagnosing middle ear infections, known as otitis media, in both children and adults. The company has created a patented handheld device that allows clinicians to swiftly and accurately distinguish between viral and bacterial infections, thereby informing appropriate treatment decisions regarding antibiotic use. This innovative application of ultrasound technology facilitates rapid data collection, enabling ease of use by healthcare professionals, including non-physician personnel. Additionally, the device features one-use-per-patient tips, which contribute to a recurring revenue model for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus was previously known as OtoMetrix Medical Technologies until its name change in July 2014.

LumiThera is a medical device company that develops photobiomodulation-based treatments for ocular diseases. It seeks to prevent vision loss and slow disease progression by using non-invasive light therapy delivered through LED-based systems, including The Valeda light delivery system for dry age-related macular degeneration and other ocular disorders. The technology aims to improve visual function, acuity, and contrast sensitivity while reducing disease activity. Founded in 2013, LumiThera is headquartered in Poulsbo, Washington.

Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, founded in 2010. The company focuses on developing innovative products to assist surgeons in improving outcomes for cancer patients. Its primary offering, Tumor Paint, utilizes a combination of a targeting peptide and a fluorescent dye that emits near-infrared light, allowing for real-time, high-resolution visualization of cancer cells during surgery. This technology enhances the detection of tumors and aids surgeons in achieving more precise and complete surgical resections across various solid tumors, including brain, breast, prostate, lung, colorectal, skin, and sarcomas. Blaze Bioscience aims to facilitate better surgical interventions and ultimately improve the lives of cancer patients through its advanced therapeutic solutions.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, specializing in the manufacturing and marketing of face mask solutions designed for CO2 sampling in sidestream capnography during sedation anesthesia. Established in 2012, the company serves a variety of healthcare settings, including hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Monitor Mask's primary product line includes the CapnoVue series, which facilitates capnography monitoring to enhance patient safety and streamline clinical workflows. By incorporating pre-formed ports in their designs, these masks enable accurate assessments of carbon dioxide levels in patients' breaths, thereby assisting clinicians in ensuring adequate oxygen supply and meeting established monitoring standards. As of 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

Textile-Based Delivery, Inc., operating under the name Nufabrx, specializes in the development and manufacturing of fabrics embedded with medications and other active ingredients. Founded in 2011 and based in Seattle, Washington, with an additional office in Minneapolis, the company offers a diverse range of products, including headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, and swimwear, all designed to release essential oils, vitamins, and cosmeceuticals during use. Nufabrx utilizes five patent-pending platform technologies that facilitate the secure and controlled delivery of these active ingredients, ensuring efficacy over extended periods and multiple laundering cycles. The company’s innovative approach aims to enhance user experience by integrating health benefits directly into everyday textiles.

Joylux, Inc. is a health and wellness company based in Seattle, Washington, specializing in women's health solutions. Founded in 2013, the company develops LED-focused medical devices aimed at addressing pelvic-floor issues and enhancing vaginal health. Joylux offers an at-home pelvic-floor toning and vaginal rejuvenation device that employs photobiomodulation technology to alleviate symptoms associated with genitourinary syndrome of menopause. The company is dedicated to providing noninvasive, effective, and affordable products that improve various aspects of women's intimate health, while also focusing on collecting health data to help women better predict and manage their symptoms during menopause.

Phytelligence, Inc. is an agricultural biotechnology company that specializes in the cultivation and provision of disease-free plants and innovative solutions for growers, nurseries, and horticultural experts. Founded in 2012 and based in Pullman, Washington, the company offers a diverse range of tissue-cultured plantlets, including pear, apple, cherry, sweet cherry, grape, and strawberry. Phytelligence utilizes advanced propagation techniques and genetic analysis services to ensure the high quality and genetic integrity of its plants, enabling clients to achieve greater profitability through improved speed to harvest and reduced input costs. Its product portfolio also includes various series of rootstocks, such as the Geneva, Gisela, and Krymsk series, contributing to healthier and more resilient crops.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound-based medical devices aimed at diagnosing middle ear infections, known as otitis media, in both children and adults. The company has created a patented handheld device that allows clinicians to swiftly and accurately distinguish between viral and bacterial infections, thereby informing appropriate treatment decisions regarding antibiotic use. This innovative application of ultrasound technology facilitates rapid data collection, enabling ease of use by healthcare professionals, including non-physician personnel. Additionally, the device features one-use-per-patient tips, which contribute to a recurring revenue model for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus was previously known as OtoMetrix Medical Technologies until its name change in July 2014.

Textile-Based Delivery, Inc., operating under the name Nufabrx, specializes in the development and manufacturing of fabrics embedded with medications and other active ingredients. Founded in 2011 and based in Seattle, Washington, with an additional office in Minneapolis, the company offers a diverse range of products, including headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, and swimwear, all designed to release essential oils, vitamins, and cosmeceuticals during use. Nufabrx utilizes five patent-pending platform technologies that facilitate the secure and controlled delivery of these active ingredients, ensuring efficacy over extended periods and multiple laundering cycles. The company’s innovative approach aims to enhance user experience by integrating health benefits directly into everyday textiles.

Resonance AI is a Seattle-based developer of an AI-driven video platform that identifies the building blocks of video content and its resonance with audiences. The platform uses machine learning to analyze elements such as dialogue and music, delivering insights on content performance, audience behavior, and potential talent fit. It supports a range of formats, including TV shows, trailers, local news, and advertisements, enabling content creators and distributors to link creative decisions with viewer responses and take actionable steps to increase viewing, subscriptions, and purchases. The company, founded in 2013 and incorporated in 2014, was formerly Transform, Inc.

Precision Image Analysis, Inc. is a provider of cloud-based remote medical image post-processing and analysis services, focusing on diagnostic medical studies, including CT and MRI scans. Established in 2012 and headquartered in Kirkland, Washington, the company serves hospitals, universities, and research institutions by offering a HIPAA-compliant platform that allows users to upload, monitor, and retrieve medical images and analyses remotely. Precision Image Analysis employs a team of trained analysts who deliver results in as few as two hours, specializing in areas such as Cardiac, Vascular, and Neuro imaging. The company’s services are designed to enhance efficiency and consistency in image analysis workflows, allowing healthcare providers to scale their operations seamlessly without the need for additional staffing or costly technology investments.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, founded in 2010. The company focuses on developing innovative products to assist surgeons in improving outcomes for cancer patients. Its primary offering, Tumor Paint, utilizes a combination of a targeting peptide and a fluorescent dye that emits near-infrared light, allowing for real-time, high-resolution visualization of cancer cells during surgery. This technology enhances the detection of tumors and aids surgeons in achieving more precise and complete surgical resections across various solid tumors, including brain, breast, prostate, lung, colorectal, skin, and sarcomas. Blaze Bioscience aims to facilitate better surgical interventions and ultimately improve the lives of cancer patients through its advanced therapeutic solutions.

LumiThera is a medical device company that develops photobiomodulation-based treatments for ocular diseases. It seeks to prevent vision loss and slow disease progression by using non-invasive light therapy delivered through LED-based systems, including The Valeda light delivery system for dry age-related macular degeneration and other ocular disorders. The technology aims to improve visual function, acuity, and contrast sensitivity while reducing disease activity. Founded in 2013, LumiThera is headquartered in Poulsbo, Washington.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, specializing in the manufacturing and marketing of face mask solutions designed for CO2 sampling in sidestream capnography during sedation anesthesia. Established in 2012, the company serves a variety of healthcare settings, including hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Monitor Mask's primary product line includes the CapnoVue series, which facilitates capnography monitoring to enhance patient safety and streamline clinical workflows. By incorporating pre-formed ports in their designs, these masks enable accurate assessments of carbon dioxide levels in patients' breaths, thereby assisting clinicians in ensuring adequate oxygen supply and meeting established monitoring standards. As of 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

Tether Technologies, Inc. specializes in preemptive key loss technology, focusing on enhancing security for individuals and businesses by preventing key loss and its associated costs. Founded in 2010 and based in Seattle, Washington, the company offers the electronic key tether (ekt), a patented solution that ensures keys remain within a 15-step radius of the user, thereby locating them before they are lost. This innovative approach reduces the financial burden and security risks linked to key loss, which can lead to expensive re-keying processes and potential breaches. Tether Technologies caters to a diverse array of industries, including security, janitorial services, property and facility management, hospitality, healthcare, and law enforcement. The ekt system is designed for scalability and can easily integrate with existing key control programs across organizations of any size.

Precision Image Analysis, Inc. is a provider of cloud-based remote medical image post-processing and analysis services, focusing on diagnostic medical studies, including CT and MRI scans. Established in 2012 and headquartered in Kirkland, Washington, the company serves hospitals, universities, and research institutions by offering a HIPAA-compliant platform that allows users to upload, monitor, and retrieve medical images and analyses remotely. Precision Image Analysis employs a team of trained analysts who deliver results in as few as two hours, specializing in areas such as Cardiac, Vascular, and Neuro imaging. The company’s services are designed to enhance efficiency and consistency in image analysis workflows, allowing healthcare providers to scale their operations seamlessly without the need for additional staffing or costly technology investments.

KPI Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, specializing in the development of therapies for unmet medical needs in the fields of autoimmunity and chronic pain. Founded in 2013, the company is actively working on several therapeutic candidates, including dalazatide, KPI-150, and KPI-190, aimed at treating systemic autoimmune diseases such as lupus, as well as CSP conopeptide for chronic pain management. KPI Therapeutics collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance drug development and improve access to innovative medicines. The company is committed to accelerating the transition of promising drug candidates through critical stages of development, ultimately addressing significant patient needs in healthcare.

Tilting Motor Works, Inc. is a company based in Snohomish, Washington, specializing in the development of leaning three-wheel conversion solutions for motorcycles. Founded in 2008, the company focuses on enhancing motorcycle performance while prioritizing safety and stability. Its innovative conversion process replaces the traditional front fork and wheel with a new front end that integrates various components such as leaning linkages, shocks, wheels, tires, fenders, brakes, hydraulics, front fairings, and mounting hardware. This patented retrofit is designed to provide riders with a higher-performing motorcycle that delivers improved handling and confidence.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, specializing in the manufacturing and marketing of face mask solutions designed for CO2 sampling in sidestream capnography during sedation anesthesia. Established in 2012, the company serves a variety of healthcare settings, including hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Monitor Mask's primary product line includes the CapnoVue series, which facilitates capnography monitoring to enhance patient safety and streamline clinical workflows. By incorporating pre-formed ports in their designs, these masks enable accurate assessments of carbon dioxide levels in patients' breaths, thereby assisting clinicians in ensuring adequate oxygen supply and meeting established monitoring standards. As of 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

LumiThera is a medical device company that develops photobiomodulation-based treatments for ocular diseases. It seeks to prevent vision loss and slow disease progression by using non-invasive light therapy delivered through LED-based systems, including The Valeda light delivery system for dry age-related macular degeneration and other ocular disorders. The technology aims to improve visual function, acuity, and contrast sensitivity while reducing disease activity. Founded in 2013, LumiThera is headquartered in Poulsbo, Washington.

Precision Image Analysis, Inc. is a provider of cloud-based remote medical image post-processing and analysis services, focusing on diagnostic medical studies, including CT and MRI scans. Established in 2012 and headquartered in Kirkland, Washington, the company serves hospitals, universities, and research institutions by offering a HIPAA-compliant platform that allows users to upload, monitor, and retrieve medical images and analyses remotely. Precision Image Analysis employs a team of trained analysts who deliver results in as few as two hours, specializing in areas such as Cardiac, Vascular, and Neuro imaging. The company’s services are designed to enhance efficiency and consistency in image analysis workflows, allowing healthcare providers to scale their operations seamlessly without the need for additional staffing or costly technology investments.

Aqueduct Critical Care develops medical devices for treating neurological conditions related to cerebrospinal fluid and intracranial pressure. Its gravity-based drainage systems are designed to provide automated regulation, reducing the need for continuous manual measurements and interventions, which helps patients move more freely and allows hospital staff to conduct tests and physical therapy without restraining mobility. The company was founded in 2013 and is based in Bothell, Washington.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound-based medical devices aimed at diagnosing middle ear infections, known as otitis media, in both children and adults. The company has created a patented handheld device that allows clinicians to swiftly and accurately distinguish between viral and bacterial infections, thereby informing appropriate treatment decisions regarding antibiotic use. This innovative application of ultrasound technology facilitates rapid data collection, enabling ease of use by healthcare professionals, including non-physician personnel. Additionally, the device features one-use-per-patient tips, which contribute to a recurring revenue model for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus was previously known as OtoMetrix Medical Technologies until its name change in July 2014.

KPI Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, specializing in the development of therapies for unmet medical needs in the fields of autoimmunity and chronic pain. Founded in 2013, the company is actively working on several therapeutic candidates, including dalazatide, KPI-150, and KPI-190, aimed at treating systemic autoimmune diseases such as lupus, as well as CSP conopeptide for chronic pain management. KPI Therapeutics collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance drug development and improve access to innovative medicines. The company is committed to accelerating the transition of promising drug candidates through critical stages of development, ultimately addressing significant patient needs in healthcare.

Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

Precision Image Analysis, Inc. is a provider of cloud-based remote medical image post-processing and analysis services, focusing on diagnostic medical studies, including CT and MRI scans. Established in 2012 and headquartered in Kirkland, Washington, the company serves hospitals, universities, and research institutions by offering a HIPAA-compliant platform that allows users to upload, monitor, and retrieve medical images and analyses remotely. Precision Image Analysis employs a team of trained analysts who deliver results in as few as two hours, specializing in areas such as Cardiac, Vascular, and Neuro imaging. The company’s services are designed to enhance efficiency and consistency in image analysis workflows, allowing healthcare providers to scale their operations seamlessly without the need for additional staffing or costly technology investments.

Tether Technologies, Inc. specializes in preemptive key loss technology, focusing on enhancing security for individuals and businesses by preventing key loss and its associated costs. Founded in 2010 and based in Seattle, Washington, the company offers the electronic key tether (ekt), a patented solution that ensures keys remain within a 15-step radius of the user, thereby locating them before they are lost. This innovative approach reduces the financial burden and security risks linked to key loss, which can lead to expensive re-keying processes and potential breaches. Tether Technologies caters to a diverse array of industries, including security, janitorial services, property and facility management, hospitality, healthcare, and law enforcement. The ekt system is designed for scalability and can easily integrate with existing key control programs across organizations of any size.